(VIANEWS) - AbbVie (ABBV), Kronos Worldwide (KRO), TCG BDC (CGBD) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. AbbVie (ABBV)
76.18% Payout Ratio
AbbVie Inc. develops, produces, and markets pharmaceuticals worldwide. HUMIRA is an injectable therapy for autoimmune Behcet's disease; SKYRIZI for moderate to severe plaque psoriasis; RINVOQ to treat mild to moderately severe active rheumatoidarthritis in adults; IMBRUVICA for adults with chronic lymphocyticleukemia (CLL) or small lymphocytic lupus (SLL); and VENCLEXTA to treat chronic HCV genotype 1-6 patients. The company also offers CREON, an exocrine-pancreatic enzyme therapy to treat hypothyroidism. Linzess/Constella is used for irritable bowel syndrome and chronic idiopathic constipation. Lupron can be used for palliative care of advanced prostate cancer and endometriosis. Botox Therapeutic will treat patients with chronic HCV genotype 1-6 infection. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. collaborates with Dragonfly Therapeutics, Inc. It was founded in 2012, and its headquarters are in North Chicago (Illinois).
Volume
Today's last reported volume for AbbVie is 7423080, 35.28% above its average volume of 5486920.
As stated by Morningstar, Inc., the next dividend payment is on Jul 13, 2022, the estimated forward annual dividend rate is 5.64 and the estimated forward annual dividend yield is 3.93%.
AbbVie's sales growth this year is anticipated to be 6.2% and a negative 6.2% for next year.
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 57.35B for the twelve trailing months.
AbbVie's sales growth for the current quarter is 7.3%. The company's growth estimates for the ongoing quarter and the next is 9.2% and 29.7%.
Volatility
AbbVie's last day, week, and month's current intraday variation average was 1.09%, 1.44%, and 1.12%, respectively.
AbbVie's highest amplitude of average volatility was 2.47% (day), 2.47% (last week), and 2.00% (last month), respectively.
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $144.22 at 14:23 EST, way under its 52-week high of $175.91 and way above its 52-week low of $105.56.
AbbVie's Moving Average
AbbVie's value is above its 50-day moving average of $143.13 and below its 200-day moving average of $145.31.2. Kronos Worldwide (KRO)
49.66% Payout Ratio
Kronos Worldwide, Inc. manufactures and sells titanium dioxide pigments (TiO2) throughout Europe, North America, Asia Pacific, as well as internationally. TiO2 is produced in two forms: rutile, anatase, to give whiteness, brightness and durability. It can also be used in paints and coatings as well as paper and fibers. Ilmenite is also produced by the company. It can be used to make sulfate process TiO2 plants. Iron-based chemicals are used for treatment and conditioning of industrial effluents. The company also provides technical support for its products. The company sells products under its KRONOS trademark through distributors and agents to paper, paint, plastics and decorative laminate manufacturers. It was established in 1916, and has its headquarters in Dallas. Kronos Worldwide, Inc., is a subsidiary Valhi, Inc.
Volume
Today's last reported volume for Kronos Worldwide is 278359, 10.92% below its average volume of 312491.
As maintained by Morningstar, Inc., the next dividend payment is on Aug 30, 2022, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 5.96%.
Kronos Worldwide's sales growth this year is anticipated to be 12.9% and 4% for next year.
Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 2.12B for the twelve trailing months.
Kronos Worldwide's sales growth is 7.2% for the ongoing quarter and 4.4% for the next. The company's growth estimates for the present quarter is 9.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.94%.
Volatility
Kronos Worldwide's last day, week, and month's current intraday variation average was 1.51%, 1.63%, and 1.74%, respectively.
Kronos Worldwide's highest amplitude of average volatility was 1.42% (day), 2.63% (last week), and 2.79% (last month), respectively.
Kronos Worldwide's Stock Yearly Top and Bottom Value
Kronos Worldwide's stock is valued at $12.91 at 14:23 EST, way under its 52-week high of $19.78 and above its 52-week low of $12.06.
Kronos Worldwide's Moving Average
Kronos Worldwide's worth is way below its 50-day moving average of $15.81 and way under its 200-day moving average of $15.73.3. TCG BDC (CGBD)
48.85% Payout Ratio
TCG BDC, Inc., is an investment company that does not offer diversification. This fund is a company for business development. It provides loans investments to U.S. middle-market companies. The company also offers debt investments in U.S. middle market companies, including first lien and senior secured loans. New York is the headquarters of this company, which was established in 2012.
Volume
Today's last reported volume for TCG BDC is 109903, 54.62% below its average volume of 242195.
As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2022, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 9.42%.
TCG BDC's sales growth this year is anticipated to be negative 1.1% and 2% for next year.
Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 177.9M for the twelve trailing months.
TCG BDC's sales growth is 7.9% for the present quarter and negative 0.2% for the next. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.67%.
Volatility
TCG BDC's last day, week, and month's current intraday variation average was 0.85%, 1.00%, and 0.95%, respectively.
TCG BDC's highest amplitude of average volatility was 1.42% (day), 2.08% (last week), and 1.69% (last month), respectively.
TCG BDC's Stock Yearly Top and Bottom Value
TCG BDC's stock is valued at $14.23 at 14:23 EST, under its 52-week high of $14.96 and way higher than its 52-week low of $12.14.
TCG BDC's Moving Average
TCG BDC's value is higher than its 50-day moving average of $13.61 and higher than its 200-day moving average of $13.96.4. Cohn & Steers (CNS)
46.84% Payout Ratio
Cohen & Steers, Inc., is a public asset management holding company. The firm's subsidiaries provide services for institutional investors such as foundations, pension funds, and endowments. Through its subsidiaries, it manages client-focused equity and fixed income portfolios as well as multi-asset, commodity, and multi-asset portfolios. Through its subsidiaries, the firm manages mutual funds that are equity, fixed income balanced, multi-asset, and multi-asset. It also manages and launches hedge funds through its subsidiaries. Through its subsidiaries, the firm is able to invest in fixed income and public equity markets around the world. It invests through its subsidiaries in real estate companies, such as real estate investment trusts and infrastructure sector. This sector is used for equity and fixed-income investments. Through its subsidiaries, the firm invests in preferred securities to fund its fixed income investments. Cohen & Steers, Inc., was established in 1986. It is based out of New York, and has additional offices in London, United Kingdom, Central, Hong Kong, Tokyo, Japan, and Seattle, Washington.
Volume
Today's last reported volume for Cohn & Steers is 63257, 37.68% below its average volume of 101514.
According to Morningstar, Inc., the next dividend payment is on Aug 11, 2022, the estimated forward annual dividend rate is 2.2 and the estimated forward annual dividend yield is 3.08%.
Cohn & Steers's sales growth this year is expected to be negative 2.6% and 0.5% for next year.
Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 615.44M for the twelve trailing months.
Cohn & Steers's sales growth is negative 6% for the ongoing quarter and negative 7.2% for the next. The company's growth estimates for the current quarter and the next is negative 14.2% and negative -29.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 50.64%.
Volatility
Cohn & Steers's last day, week, and month's current intraday variation average was 1.01%, 1.24%, and 1.04%, respectively.
Cohn & Steers's highest amplitude of average volatility was 1.70% (day), 2.46% (last week), and 1.87% (last month), respectively.
Cohn & Steers's Stock Yearly Top and Bottom Value
Cohn & Steers's stock is valued at $74.65 at 14:23 EST, way below its 52-week high of $101.22 and way above its 52-week low of $62.01.
Cohn & Steers's Moving Average
Cohn & Steers's value is higher than its 50-day moving average of $71.89 and below its 200-day moving average of $79.16.5. Parker (PH)
31.81% Payout Ratio
Parker-Hannifin Corporation produces and sells motion control technology and systems worldwide. Two segments of the company are Diversified Industrial and Aerospace Systems. Diversified Industrial offers sealant, shielding and thermal products, as well as adhesives, coatings and noise vibration and harshness. The segment is sold to OEMs and distributors that serve replacement markets for manufacturing, packaging and processing. The Aerospace Systems segment includes products that can be used in military and commercial aircraft and engine programs. These include control actuation system and components as well as engine exhaust nozzles. Fluid conveyance systems are also available. Fuel systems and parts, hydraulic systems systems, inerting systems for fuel tanks, fuel systems, hydraulic components and fuel system components. Lubrication and control components can be used to control pilot controls and pneumatic control elements. Thermal management products and wheels as well as fluid delivery and atomization. The segment sells its products to OEMs as well as end-users. The company markets its products via direct sales employees, independent distributors and sales reps. Cleveland is the headquarters of this company, which was established in 1917.
Volume
Today's last reported volume for Parker is 730100, 2.73% below its average volume of 750633.
As claimed by Morningstar, Inc., the next dividend payment is on May 11, 2022, the estimated forward annual dividend rate is 5.32 and the estimated forward annual dividend yield is 1.84%.
Parker's sales growth this year is expected to be 9.7% and 2.6% for next year.
Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 15.63B for the twelve trailing months.
Parker's sales growth for the current quarter is 2.6%. The company's growth estimates for the current quarter and the next is 6.6% and 3.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.66%.
Volatility
Parker's last day, week, and month's current intraday variation average was 2.86%, 1.13%, and 1.52%, respectively.
Parker's highest amplitude of average volatility was 2.29% (day), 2.29% (last week), and 2.34% (last month), respectively.
Parker's Stock Yearly Top and Bottom Value
Parker's stock is valued at $259.61 at 14:23 EST, way under its 52-week high of $340.00 and way above its 52-week low of $230.44.